Treatments | Concentrations | Pupal period (days) | Total percent of pupal mortality | Weight of Pupae (mg) | Adult longevity | |||
---|---|---|---|---|---|---|---|---|
Female | Male | Female | Male | Female | Male | |||
T1 | 1.20 × 107 | 11.99 ± 0.40a | 11.33 ± 0.65a | 72.73 | 164.44 ± 4.84b | 188.89 ± 2.22ab | 3.50 ± 0.64c | 3.50 ± 0.86b |
T2 | 2.83 × 106 | 11.48 ± 0.47ab | 10.88 ± 0.69ab | 62.06 | 153.89 ± 7.22b | 165.33 ± 1.33ab | 4.25 ± 0.47c | 3.71 ± 0.47b |
T3 | 2.00 × 106 | 9.81 ± 0.50b | 9.48 ± 0.55ab | 62.50 | 170.22 ± 1.93b | 175.55 ± 9.49ab | 5.50 ± 0.28bc | 4.00 ± 0.70b |
T4 | 1.29 × 105 | 10.94 ± 0.34ab | 10.94 ± 0.34ab | 55.17 | 157.77 ± 8.01b | 139.22 ± 9.33b | 5.75 ± 0.62bc | 5.51 ± 0.64ab |
T5 | 5.69 × 104 | 11.41 ± 0.62ab | 10.21 ± 0.34ab | 40.74 | 149.99 ± 8.81ab | 167.77 ± 22.79ab | 7.00 ± 0.70ab | 5.67 ± 0.62ab |
T6 | Control | 11.50 ± 0.46ab | 9.01 ± 0.38b | 8.10 | 202.42 ± 9.87a | 201.11 ± 11a | 9.25 ± 0.40a | 7.75 ± 0.47a |